International Primary Care Respiratory Group (IPCRG) Guidelines: management of allergic rhinitis.
The association between the upper and lower airways has been recognised for almost 2000 years. Epidemiological data suggest that most asthma patients also suffer from allergic rhinitis, and that both diseases share similar trigger factors and pathophysiology. This IPCRG Guideline on the management of rhinitis in primary care is fully consistent with the ARIA guidelines. It highlights the treatment goals and the classification of the condition according to symptom frequency (intermittent or persistent) and severity (mild or moderate-severe). It covers the need for allergen avoidance, pharmacologic therapy including immunotherapy, alternative therapies, management of ocular symptoms, the management of co-existing allergic rhinitis and asthma, and the need for follow-up and ongoing care for patients with rhinitis.
Price
David
D
Department of General Practice, University of Aberdeen, Foresterhill Health Centre, Westburn Road, Aberdeen, AB25 2AY, UK. David@respiratoryresearch.org
Bond
Christine
C
Bouchard
Jacques
J
Costa
Rui
R
Keenan
Joseph
J
Levy
Mark L
ML
Orru
Mari
M
Ryan
Dermot
D
Walker
Samantha
S
Watson
Margaret
M
D018926:Anti-Allergic Agents / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D002867:Chromones / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D014663:Nasal Decongestants / Q000627:therapeutic use; D011247:Pregnancy; D011320:Primary Health Care / Q000592:standards*; D012221:Rhinitis, Allergic, Perennial / Q000628:therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy*
D018926:Anti-Allergic Agents; D018680:Cholinergic Antagonists; D002867:Chromones; D005938:Glucocorticoids; D020024:Leukotriene Antagonists; D014663:Nasal Decongestants